Global Expression Vectors Market Size (2024 - 2029)

Expression Vectors Market Analysis

The expression vectors market is expected to register a CAGR of 5.6% over the forecast period, 2022-2027.

The market has a slightly positive impact due to the pandemic. The development of therapeutic and preventive strategies requires an accurate understanding of the role that proteins play in the SARS-CoV-2 infection process and progression of COVID-19. The vast field of proteomics is well equipped with the technologies needed to help in facing this challenge. In an article published in the Journal of Proteins and Proteomics in October 2020, researchers have highlighted that the developments in proteome technologies will not only accelerate progress in addressing the coronavirus pandemics but could also prove invaluable in tackling the current COVID-19 crisis. According to a report published by Journal of the American College of Cardiology: Basic to Translational Science, on Plasma Proteomics of COVID-19-Associated Cardiovascular Complications, on May 2022, key biological pathways linked to cardiac injury and stress in COVID-19 are identified by plasma proteomics. The von Willebrand factor (VWF)-cleaving protease ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, 13), whose loss-of-function results in microvascular thrombosis, exhibits the most significant inverse correlation with myocardial damage among the 4,996 analytes examined in COVID-19. The market is expected to gain traction due to the significant increase in the COVID 19 cases globally.

The propelling factors for the growth of the expression vector market include the rise in the R&D activity in the pharmaceutical sector, opportunities in the field of proteomics, and advancements in the biologics market set to boost the market growth and the increasing incidences of lifestyle diseases, infectious diseases and genetic disorders. According to the World Health Organization (WHO) 2021, non-communicable diseases (NCDs) are causative of 41 million deaths yearly, equivalent to 71% of the total death rate. More than 15 million people die each year from non-communicable diseases between 30 and 69 years. About 85% of these "premature" deaths occur in low- and middle-income countries. Also, 77% of all non-communicable disease casualties are in low- and middle-income countries. Cardiovascular diseases account for most non-communicable disease deaths, or 17.9 million fatalities annually, followed by cancers (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million). These growing cases of non-communicable diseases are expected to further increase the demand for biologics in treating chronic diseases. Biologics have played a crucial role in the treatment process of many health issues. The growing demand for biologicals increases the prospects of its manufacturing using the expression vector systems, thus, boosting the market growth.

Therefore, the factors mentioned above are attributed collectively to the studied market growth over the forecast period. However high cost of protein expression systems is expected to hinder the market growth over the forecast period.

Expression Vectors Industry Segmentation

As per the scope of the report, expression vector, also known as an expression construct, are plasmid or virus that is specially designed for expressing genes in a cell. It is a vector widely used for protein production. The expression vectors market is segmented by Host Type (Bacterial Expression Vectors, Mammalian Expression Vectors, Insect Expression Vectors, Yeast Expression Vectors and Other Expression Vectors), Application (Therapeutic Applications, Research Applications and Industrial Applications), End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), and Academic Research Institutes), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.